Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.7710
-0.0010 (-0.13%)
Nov 2, 2026, 5:10 PM CET
Intervacc AB Earnings Call Transcripts
Fiscal Year 2026
-
Breakthrough vaccines for horses and pigs are driving growth, with Strangvac showing high efficacy and safety, and U.S. market entry expected to be a major catalyst. PiggyBac addresses a large unmet need, and label changes plus new launches in Europe and beyond are set to boost adoption.